Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
BeyondSpring
Biotech
BeyondSpring axes 35% of US staff after November drug rejection
BeyondSpring parts ways with 35% of its U.S. staff as the company reels from a November FDA rejection and awaits answers from China regulators.
Kyle LaHucik
Jan 12, 2022 10:05am
BeyondSpring lurches down as FDA rejects plinabulin
Dec 3, 2021 7:45am
BeyondSpring, flying high from phase 3 success, inks cancer deal
Aug 27, 2021 8:20am
BeyondSpring lands on Nasdaq with $54M IPO
Mar 9, 2017 10:44am